News
Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...
13d
Stocktwits on MSNKenvue CEO Thibaut Mongon Steps Down, Director Kirk Perry To Take On Interim CEO RoleKenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry ...
American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...
Kenvue, formerly part of Johnson & Johnson, announces CEO Thibaut Mongon's departure as it undergoes a strategic review.
Thibaut Mongon is CEO and member of the board of directors at Johnson & Johnson’s consumer health spinoff, Kenvue.
As announced in November 2021, the planned separation would create two global leaders– the new Johnson& Johnson and the New Consumer Health Company- that are better positioned to deliver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results